BIOGEN INC. Payments to Acquire Interest in Subsidiaries and Affiliates
BIOGEN INC. (BIIB) reported Payments to Acquire Interest in Subsidiaries and Affiliates of $141.80 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-07-22.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates · last filed 2020-07-22
- 2020-06-30: Payments to Acquire Interest in Subsidiaries and Affiliates 6 month $141.80M.
- 2019-06-30: Payments to Acquire Interest in Subsidiaries and Affiliates 6 month $0.00.
| Period end | Payments to Acquire Interest in Subsidiaries and Affiliates 6 month |
|---|---|
| 2020-06-30 | $141.80M 10-Q · filed 2020-07-22 |
| 2019-06-30 | $0.00 10-Q · filed 2020-07-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |